(Q40579582)

21 September 2017

MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model (English)

1 reference

21 September 2017

6

Michael Weller

1 reference

21 September 2017

Ulrich Herrlinger

1

1 reference

21 September 2017

Steffen Aulwurm

2

1 reference

21 September 2017

Herwig Strik

3

1 reference

21 September 2017

Simone Weit

4

1 reference

21 September 2017

Ulrike Naumann

5

1 reference

21 September 2017

1 January 2004

1 reference

Journal of Neuro-Oncology

21 September 2017

1 reference

21 September 2017

66

1 reference

21 September 2017

1-2

1 reference

21 September 2017

147-154

1 reference

https://scigraph.springernature.com/pub.10.1023/b:neon.0000013497.04322.fc

21 September 2017

0 references

cites work

Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges

1 reference

12 December 2020

Heat shock protein expression in human gliomas.

1 reference

12 December 2020

Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro.

1 reference

12 December 2020

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

1 reference

12 December 2020

Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes

1 reference

12 December 2020

Vaccination for experimental gliomas using GM-CSF-transduced glioma cells

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

Monocyte inflammatory protein-1 alpha facilitates priming of CD8(+) T cell responses to exogenous viral antigen

1 reference

12 December 2020

Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro

1 reference

12 December 2020

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

1 reference

12 December 2020

Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells.

1 reference

12 December 2020

Studies on the chemotherapy of experimental brain tumors: development of an experimental model

1 reference

12 December 2020

RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations

1 reference

12 December 2020

Dendritic cells and the control of immunity

1 reference

12 December 2020

Human chemokines: an update

1 reference

12 December 2020

Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses

1 reference

12 December 2020

A candidate for cancer gene therapy: MIP-1 alpha gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice

1 reference

12 December 2020

Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.

1 reference

12 December 2020

10.1023/B:NEON.0000013497.04322.FC

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference